Inhibition of human T lymphoblast proliferation by hydroquinone

Qing Li, Lisa Geiselhart, James N. Mittler, Stanley P. Mudzinski, David A. Lawrence, Brian M. Freed

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Abstract

Hydroquinone (HQ) is a major metabolite of benzene and is present in large quantities in cigarette tar as a result of the combustion of tobacco leaf pigments. We hypothesize that the immunosuppressive effects of cigarette smoking are due, in part, to the deposition of large quantities of HQ in the lungs. Exposure of primary human T lymphoblasts (HTL) in vitro to 50 μM HQ blocked IL-2-dependent proliferation by >90% with no loss in viability. Inhibition of DNA synthesis was observed immediately after the addition of HQ to the cells. However, this effect could be reversed up to 6 hr later by simply washing the cells and reculturing them in the absence of HQ. HQ did not significantly alter intracellular glutathione levels up to 24 hr later, and the presence of 50 μM 2-mercaptoethanol or 500 μM dithiothreitol during the treatment did not prevent inhibition of DNA synthesis. HQ did not block binding of 125I-IL-2 to the cells, but inhibited the IL-2-dependent progression of HTL through S phase of the cell cycle. These observations demonstrate that HQ, in concentrations comparable to those found in cigarette tar, is a potent inhibitor of IL-2-dependent T cell proliferation and may therefore help to explain the potent immunosuppressive effects of cigarette smoke on lung T lymphocytes.

Original languageEnglish (US)
Pages (from-to)317-323
Number of pages7
JournalToxicology and Applied Pharmacology
Volume139
Issue number2
DOIs
StatePublished - Aug 1996
Externally publishedYes

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Fingerprint

Dive into the research topics of 'Inhibition of human T lymphoblast proliferation by hydroquinone'. Together they form a unique fingerprint.

Cite this